First Time Loading...

Pharmaron Beijing Co Ltd
SZSE:300759

Watchlist Manager
Pharmaron Beijing Co Ltd Logo
Pharmaron Beijing Co Ltd
SZSE:300759
Watchlist
Price: 19.75 CNY -1% Market Closed
Updated: May 2, 2024

Pharmaron Beijing Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pharmaron Beijing Co Ltd
Revenue Peer Comparison

Comparables:
603259
2269
300347
1548
W
2268

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Pharmaron Beijing Co Ltd
SZSE:300759
Revenue
¥11.5B
CAGR 3-Years
31%
CAGR 5-Years
32%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Revenue
¥40.3B
CAGR 3-Years
35%
CAGR 5-Years
33%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Revenue
¥17B
CAGR 3-Years
45%
CAGR 5-Years
46%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Revenue
¥7.4B
CAGR 3-Years
32%
CAGR 5-Years
26%
CAGR 10-Years
36%
Genscript Biotech Corp
HKEX:1548
Revenue
$839.5m
CAGR 3-Years
29%
CAGR 5-Years
29%
CAGR 10-Years
N/A
W
WuXi XDC Cayman Inc
HKEX:2268
Revenue
¥990.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Pharmaron Beijing Co Ltd's Revenue?
Revenue
11.5B CNY

Based on the financial report for Dec 31, 2023, Pharmaron Beijing Co Ltd's Revenue amounts to 11.5B CNY.

What is Pharmaron Beijing Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
32%

Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Pharmaron Beijing Co Ltd have been 31% over the past three years , 32% over the past five years .